Sulesomab

Known as: IMMU-MN3, monoclonal antibody IMMU-MN3 
 
National Institutes of Health

Papers overview

Semantic Scholar uses AI to extract papers important to this topic.
2012
2012
perts E. Successful treatment of disseminated measles in a patient with acquired immunodefi ciency syndrome: consideration of… (More)
Is this relevant?
2003
2003
UNLABELLED 99mTc-Sulesomab, the Fab fragment of anti-NCA-90, is used as an in vivo granulocyte labeling agent for imaging… (More)
Is this relevant?
Highly Cited
1999
Highly Cited
1999
Two major peroxidases are secreted by the fungus Pleurotus eryngii in lignocellulose cultures. One is similar to Phanerochaete… (More)
Is this relevant?
1998
1998
After 10 years of clinical trials in patients with advanced cancer, monoclonal antibodies (mAbs) against cell surface antigens… (More)
  • table 1
  • table 2
  • figure 1
  • table 3
Is this relevant?
1995
1995
1976 strain in four bases (<1%). No differences were seen when the polymerase gene PCR products (~350 bp) from those four… (More)
Is this relevant?
1994
1994
In addition to their application in organ transplantation, immunosuppressive drugs are valuable tools for studying signal… (More)
  • figure 1
  • figure 2
  • figure 3
  • figure 4
Is this relevant?
1991
1991
Manganese peroxidase, produced by some white-rot fungi during lignin degradation, catalyzes the oxidation of Mn2+ to Mn3… (More)
  • table I
  • figure 1
  • figure 2
Is this relevant?
1990
1990
Veratryl alcohol (3,4-dimethoxybenzyl alcohol) appears to have multiple roles in lignin degradation by Phanerochaete… (More)
  • figure 1
  • figure 3
  • figure 4
  • figure 5
  • figure 6
Is this relevant?
Highly Cited
1985
Highly Cited
1985
We have shown that a mixture of murine leukemia viruses (MuLV) causes the acute onset of lymphoproliferation and… (More)
  • table I
  • table III
  • figure 1
  • table IV
  • table V
Is this relevant?
1985
1985
Albumin, transferrin and 'transmanganin' have all been proposed as the major Mn-binding ligand in plasma. The present… (More)
Is this relevant?